Generics Bulletin is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Video Roundtable: Industry Leaders Talk COVID-19, Strategy And The Year Ahead

Accord, mAbxience, PharmEvo And Sandoz Leaders Discuss Priorities For The Sector

Executive Summary

In this exclusive video roundtable discussion, leaders from across the off-patent industry talk about the COVID-19 pandemic and the industry’s response, as well as highlighting key regulatory, policy and strategic developments that may have flown under the radar in the past year.

You may also be interested in...



Mabxience Expands Biosimilar Capacity

Mabxience has announced plans to bolster its biosimilar manufacturing capacity as well as giving a boost to its CDMO business by expanding its facility in León, Spain.

Accord Takes A Trio Of Awards

Accord Healthcare took home a trio of prizes at the Global Generics & Biosimilars Awards 2020, with other winners including Alvogen, Aurobindo, Dr Reddy’s, Eurofarma, Insud Pharma, Macleods, Pinsent Masons, Samsung Bioepis, Sandoz, Stada and Zentiva.

Action Needed To Prevent Post-Brexit Catastrophe In Northern Ireland

Action is needed from both the UK government and the European Commission to prevent a collapse of Northern Ireland’s generics market, according to the BGMA.

Topics

UsernamePublicRestriction

Register

GB150438

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel